Replies to post #9092 on Innovus Pharmaceuticals Inc. (fka INNV)

[Honeycomb777]

I sure would think so. They both stand to benefit when Fluti does well! Little downside - all upside ! Novalere had some nice Royalty terms and Hikma seems much more flexible. Convinced Hoffman ochestrated the deal and used the 5 yr warrants at 15 as the golden carrot. Sweet i hope it does go down (honestly do) to scoop up more and lower my basis. Good things ahead, watch Vesele sales skyrocket in June